IP Library Granted Patent US 10,406,366
Granted Patent B2
US 10,406,366 · App. 12/150,654 · Granted Sep 10, 2019

Transvenous phrenic nerve stimulation system

Inventors: Randy W. Westlund (River Falls, WI); Mark Gelfand (New York, NY)
Assignee: RESPICARDIA, INC.
A61N1/3611A61N1/05A61N1/0551A61N1/0558A61N1/3601A61N1/3684
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,406,366
App. No.
12/150,654
Granted
Sep 10, 2019
Kind
B2
Abstract

A lead system and method of use for treating breathing disorders by the transvenous stimulation of the phrenic nerve. The lead is implanted in a vein near one portion of the phrenic nerve.

Claims (26)

1. A method of treating a patient comprising:

placing a lead in a brachiocephalic vein and proximate a left pericardiophrenic vein, the lead having at least one electrode;

positioning the at least one electrode within the left pericardiophrenic vein and adjacent a left phrenic nerve;

implanting a pulse generator for supplying electrical stimulation energy to said phrenic nerve;

delivering the electrical stimulation energy at a time after an onset of a breath, whereby the electrical stimulation energy delivered is configured to:

arrest motion of a hemidiaphragm innervated by said phrenic nerve; and

extend a duration of the stimulated breath.

2. The method of claim 1 , wherein the electrical stimulation energy is delivered such that a right phrenic nerve remains under normal physiologic control.

3. The method of claim 1 , wherein the electrical stimulation energy is delivered via a stimulation pulse having a shape wherein an amplitude of the electrical stimulation energy increases over time within the pulse.

4. The method of claim 1 , wherein the electrical stimulation energy is delivered via a stimulation pulse having a shape wherein an amplitude increases over time and then decreases over time within the pulse.

5. The method of claim 1 , wherein the electrical stimulation energy is delivered via a series of stimulation pulses that have increasing amplitudes over a period of time.

6. The method of claim 1 , wherein the electrical stimulation energy is delivered episodically without regard to sensed conditions.

7. The method of claim 1 , wherein the lead comprises a tapered distal tip.

8. The method of claim 1 , wherein the lead comprises a lead body and the lead body forms a guidewire lumen.

9. The method of claim 1 , wherein the lead comprises a drug eluting coating.

10. The method of claim 1 further comprising a step of inserting a guidewire at least one centimeter into the left pericardiophrenic vein and advancing the lead over the guidewire.

11. The method of claim 1 , comprising positioning a bend of the lead in contact with an ostium of the left pericardiophrenic vein.

12. The method of claim 1 , comprising positioning a first bend of the lead in contact with a wall of the brachiocephalic vein.

13. The method of claim 12 , comprising positioning a second bend of the lead in contact with a wall of the left pericardiophrenic vein.

14. The method of claim 1 comprising:

delivering the electrical stimulation energy at a magnitude of stimulation to

avoid incidental stimulation of cardiac tissue.

15. The method of claim 14 , wherein the lead exerts a bias force to retain a distal tip of the lead substantially immobile.

16. The method of claim 14 , comprising positioning a first bend of the lead in contact with a wall of the brachiocephalic vein.

17. The method of claim 16 , comprising positioning a second bend of the lead in contact with a wall of the left pericardiophrenic vein.

18. The method of claim 14 , comprising positioning a bend of the lead in contact with an ostium of the left pericardiophrenic vein.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 056267 FRAME: 0334. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 25, 2021
From: RESPICARDIA, INC.
To: ZOLL RESPICARDIA, INC.
Reel/Frame 056366/0506 →
CHANGE OF NAME Recorded May 17, 2021
From: RESPICARDIA, INC.
To: ZOLL RESPICARDIA, INC.
Reel/Frame 056267/0334 →
SECURITY INTEREST Recorded Dec 5, 2017
From: RESPICARDIA, INC.
To: ZOLL MEDICAL CORPORATION
Reel/Frame 044298/0216 →
SECURITY INTEREST Recorded Dec 5, 2017
From: RESPICARDIA, INC.
To: CANTOR FITZGERALD SECURITIES, AS AGENT
Reel/Frame 044298/0370 →
CHANGE OF NAME Recorded May 6, 2011
From: CARDIAC CONCEPTS, INC.
To: RESPICARDIA, INC.
Reel/Frame 026240/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2008
From: GELFAND, MARK; WESTLUND, RANDY
To: CARDIAC CONCEPTS, INC.
Reel/Frame 021342/0724 →
Continuity (3)
Continuation In Part 11601150 · Nov 17, 2006
Provisional Application 60926910 · Apr 30, 2007
Related Publication 20090036947A1 · Feb 5, 2009
Cited By (10)
US 12,268,877 US 12,357,828 US 12,403,312 US 12,415,079 US 12,569,681 US 12,613,624 US 12,616,839 US 12,623,080 US 12,649,062 US 12,708,775